header circle small  header circle big

EULAR 2018 - SATELLITE SYMPOSIUM

THE CHALLENGES OF MULTI-MORBIDITIES IN RA:IL-6 AND CHRONIC INFLAMMATION

This programme is hosted by Sanofi Genzyme and Regeneron Speakers were compensated by Sanofi Genzyme and Regeneron This session is intended for healthcare professionals

section shadow circle small circle medium circle mobile

Missed 2018?

Chaired by Professor Peter Taylor from the University of Oxford, the EULAR 2018 satellite symposium entitled ‘The challenges of multi-morbidities in RA: IL-6 and chronic inflammation’ was presented at the June 2018 congress in Amsterdam.

Three speakers delivered presentations focused on the impact of multi-morbidity on the management and long-term outcomes of RA, and on the role of IL-6 signaling in RA.

The session concluded with an interactive Q&A session, during which the faculty and audience discussed the management of multi-morbidity in RA.

FACULTY

Peter Taylor

Professor Musculoskeletal Sciences, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, UK,

Michael Nurmohamed

Clinical Scientist and Rheumatologist, VU University Medical Center Amsterdam, Netherlands

Ernest Choy

Professor of Rheumatology, Cardiff Institute of Infection and Immunity, Cardiff University, UK

Mark Genovese

Professor of Medicine and Director of the Rheumatology Clinic, Division of Immunology and Rheumatology Stanford University, USA